Skip to main content

Advertisement

Log in

Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

The authors will make the raw data presented in this article available.

References

  1. Nezu T, Aoki S, Ochi K, Sugihara S, Takahashi T, Hosomi N, Maruyama H, Matsumoto M (2015) A case of recurrent ischemic stroke involving subacute, progressive intracranial cerebral arterial sclerosis prior to diagnosis with JAK2-mutated polycythemia vera. J Stroke Cerebrovasc Dis 24:e4–e6

    Article  PubMed  Google Scholar 

  2. Ayalew Tefferi TB (2020) Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol 12:1599–1613

    Article  Google Scholar 

  3. Barbui TCARE (2014) In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 19:301–303

    Google Scholar 

  4. Griesshammer M, Kiladjian J, Besses C (2019) Thromboembolic events in polycythemia vera. Ann Hematol 98:1071–1082

    Article  PubMed  PubMed Central  Google Scholar 

  5. Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A (2018) The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 8(2):15

  6. Landolfi R, Di Gennaro L (2008) Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica 93:331–335

    Article  CAS  PubMed  Google Scholar 

  7. Cerquozzi S, Barraco D, Lasho T, Finke C, Hanson CA, Ketterling RP, Pardanani A, Gangat N, Tefferi A (2017) Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood Cancer J 7(12):662

  8. Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T (2013) CYTO-PV CG: Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med 368:22–33

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed equally to the manuscript.

Corresponding author

Correspondence to Chun-min Li.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wen, Jh., Ren, Hl., Zhang, Wd. et al. Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera. Ann Hematol 102, 3289–3290 (2023). https://doi.org/10.1007/s00277-023-05403-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05403-2

Navigation